APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glycopeptide Antibiotics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Glycopeptide Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchGlycopeptide Antibiotics Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Glycopeptide Antibiotics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Glycopeptide Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glycopeptide Antibiotics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Glycopeptide Antibiotics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Glycopeptide Antibiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Glycopeptide Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glycopeptide Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glycopeptide Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Glycopeptide Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glycopeptide Antibiotics include Allergan, Alvogen, ANI Pharmaceuticals, Aurobindo Pharma, Hikma Pharmaceuticals plc, Lytix Biopharma, Theravance Biopharma, Eli Lilly and Company and Shenwei Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Glycopeptide Antibiotics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glycopeptide Antibiotics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glycopeptide Antibiotics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Glycopeptide Antibiotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Glycopeptide Antibiotics Segment by Company

Allergan

Alvogen

ANI Pharmaceuticals

Aurobindo Pharma

Hikma Pharmaceuticals plc

Lytix Biopharma

Theravance Biopharma

Eli Lilly and Company

Shenwei Pharmaceutical

Zhejiang Hisun Pharmaceutical Co., Ltd.

Glycopeptide Antibiotics Segment by Type

Vancomycin

Teicoplanin

Bleomycin

Glycopeptide Antibiotics Segment by Application

Enterococcus Treatment

Staphylococcus Aureus Treatment

Glycopeptide Antibiotics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycopeptide Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycopeptide Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycopeptide Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Glycopeptide Antibiotics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glycopeptide Antibiotics industry.

Chapter 3: Detailed analysis of Glycopeptide Antibiotics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glycopeptide Antibioticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Glycopeptide Antibiotics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Vancomycin Table 3. Key Players of Teicoplanin Table 4. Key Players of Bleomycin Table 4. Global Glycopeptide Antibiotics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Enterococcus Treatment Table 6. Key Players of Staphylococcus Aureus Treatment Table 7. Global Glycopeptide Antibiotics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Glycopeptide Antibiotics Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Glycopeptide Antibiotics Market Share by Region (2021-2026) Table 10. Global Glycopeptide Antibiotics Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Glycopeptide Antibiotics Market Share by Region (2027-2032) Table 12. Glycopeptide Antibiotics Industry Trends Table 13. Glycopeptide Antibiotics Industry Drivers Table 14. Glycopeptide Antibiotics Industry Opportunities and Challenges Table 15. Glycopeptide Antibiotics Industry Restraints Table 16. Global Glycopeptide Antibiotics Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Glycopeptide Antibiotics Revenue Market Share by Company (2021-2026) Table 18. Global Glycopeptide Antibiotics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Glycopeptide Antibiotics Key Company Head Office and Area Served Table 20. Global Glycopeptide Antibiotics Company, Product Type & Application Table 21. Global Glycopeptide Antibiotics Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Glycopeptide Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Glycopeptide Antibiotics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Glycopeptide Antibiotics Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Glycopeptide Antibiotics Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Glycopeptide Antibiotics Revenue Market Share by Type (2021-2026) Table 28. Global Glycopeptide Antibiotics Revenue Market Share by Type (2027-2032) Table 29. Global Glycopeptide Antibiotics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Glycopeptide Antibiotics Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Glycopeptide Antibiotics Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Glycopeptide Antibiotics Revenue Market Share by Application (2021-2026) Table 33. Global Glycopeptide Antibiotics Revenue Market Share by Application (2027-2032) Table 34. Allergan Company Information Table 35. Allergan Business Overview Table 36. Allergan Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Allergan Glycopeptide Antibiotics Product Portfolio Table 38. Allergan Recent Development Table 39. Alvogen Company Information Table 40. Alvogen Business Overview Table 41. Alvogen Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Alvogen Glycopeptide Antibiotics Product Portfolio Table 43. Alvogen Recent Development Table 44. ANI Pharmaceuticals Company Information Table 45. ANI Pharmaceuticals Business Overview Table 46. ANI Pharmaceuticals Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. ANI Pharmaceuticals Glycopeptide Antibiotics Product Portfolio Table 48. ANI Pharmaceuticals Recent Development Table 49. Aurobindo Pharma Company Information Table 50. Aurobindo Pharma Business Overview Table 51. Aurobindo Pharma Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Aurobindo Pharma Glycopeptide Antibiotics Product Portfolio Table 53. Aurobindo Pharma Recent Development Table 54. Hikma Pharmaceuticals plc Company Information Table 55. Hikma Pharmaceuticals plc Business Overview Table 56. Hikma Pharmaceuticals plc Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Hikma Pharmaceuticals plc Glycopeptide Antibiotics Product Portfolio Table 58. Hikma Pharmaceuticals plc Recent Development Table 59. Lytix Biopharma Company Information Table 60. Lytix Biopharma Business Overview Table 61. Lytix Biopharma Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Lytix Biopharma Glycopeptide Antibiotics Product Portfolio Table 63. Lytix Biopharma Recent Development Table 64. Theravance Biopharma Company Information Table 65. Theravance Biopharma Business Overview Table 66. Theravance Biopharma Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Theravance Biopharma Glycopeptide Antibiotics Product Portfolio Table 68. Theravance Biopharma Recent Development Table 69. Eli Lilly and Company Company Information Table 70. Eli Lilly and Company Business Overview Table 71. Eli Lilly and Company Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Eli Lilly and Company Glycopeptide Antibiotics Product Portfolio Table 73. Eli Lilly and Company Recent Development Table 74. Shenwei Pharmaceutical Company Information Table 75. Shenwei Pharmaceutical Business Overview Table 76. Shenwei Pharmaceutical Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Shenwei Pharmaceutical Glycopeptide Antibiotics Product Portfolio Table 78. Shenwei Pharmaceutical Recent Development Table 79. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information Table 80. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 81. Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Product Portfolio Table 83. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development Table 84. North America Glycopeptide Antibiotics Market Size by Type (2021-2026) & (US$ Million) Table 85. North America Glycopeptide Antibiotics Market Size by Type (2027-2032) & (US$ Million) Table 86. North America Glycopeptide Antibiotics Market Size by Application (2021-2026) & (US$ Million) Table 87. North America Glycopeptide Antibiotics Market Size by Application (2027-2032) & (US$ Million) Table 88. North America Glycopeptide Antibiotics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Glycopeptide Antibiotics Market Size by Country (2021-2026) Table 90. North America Glycopeptide Antibiotics Market Size by Country (2027-2032) Table 91. Europe Glycopeptide Antibiotics Market Size by Type (2021-2026) & (US$ Million) Table 92. Europe Glycopeptide Antibiotics Market Size by Type (2027-2032) & (US$ Million) Table 93. Europe Glycopeptide Antibiotics Market Size by Application (2021-2026) & (US$ Million) Table 94. Europe Glycopeptide Antibiotics Market Size by Application (2027-2032) & (US$ Million) Table 95. Europe Glycopeptide Antibiotics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Glycopeptide Antibiotics Market Size by Country (2021-2026) Table 97. Europe Glycopeptide Antibiotics Market Size by Country (2027-2032) Table 98. China Glycopeptide Antibiotics Market Size by Type (2021-2026) & (US$ Million) Table 99. China Glycopeptide Antibiotics Market Size by Type (2027-2032) & (US$ Million) Table 100. China Glycopeptide Antibiotics Market Size by Application (2021-2026) & (US$ Million) Table 101. China Glycopeptide Antibiotics Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Glycopeptide Antibiotics Market Size by Type (2021-2026) & (US$ Million) Table 103. Asia Glycopeptide Antibiotics Market Size by Type (2027-2032) & (US$ Million) Table 104. Asia Glycopeptide Antibiotics Market Size by Application (2021-2026) & (US$ Million) Table 105. Asia Glycopeptide Antibiotics Market Size by Application (2027-2032) & (US$ Million) Table 106. Asia Glycopeptide Antibiotics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Glycopeptide Antibiotics Market Size by Country (2021-2026) Table 108. Asia Glycopeptide Antibiotics Market Size by Country (2027-2032) Table 109. South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Type (2021-2026) & (US$ Million) Table 110. South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Type (2027-2032) & (US$ Million) Table 111. South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Application (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Application (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Country (2021-2026) Table 115. South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Country (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Glycopeptide Antibiotics Product Image Figure 2. Global Glycopeptide Antibiotics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Glycopeptide Antibiotics Market Share by Type: 2025 VS 2032 Figure 4. Vancomycin Image Figure 5. Teicoplanin Image Figure 6. Bleomycin Image Figure 7. Global Glycopeptide Antibiotics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Glycopeptide Antibiotics Market Share by Application: 2025 VS 2032 Figure 9. Enterococcus Treatment Image Figure 10. Staphylococcus Aureus Treatment Image Figure 11. Global Glycopeptide Antibiotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 13. Global Glycopeptide Antibiotics Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Glycopeptide Antibiotics Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Glycopeptide Antibiotics Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Glycopeptide Antibiotics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Glycopeptide Antibiotics Revenue Market Share by Type (2021-2032) Figure 20. Global Glycopeptide Antibiotics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Glycopeptide Antibiotics Revenue Market Share by Application (2021-2032) Figure 22. North America Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 23. North America Glycopeptide Antibiotics Market Share by Type (2021-2032) Figure 24. North America Glycopeptide Antibiotics Market Share by Application (2021-2032) Figure 25. North America Glycopeptide Antibiotics Market Share by Country (2021-2032) Figure 26. United States Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 27. Canada Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 29. Europe Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 30. Europe Glycopeptide Antibiotics Market Share by Type (2021-2032) Figure 31. Europe Glycopeptide Antibiotics Market Share by Application (2021-2032) Figure 32. Europe Glycopeptide Antibiotics Market Share by Country (2021-2032) Figure 33. Germany Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 34. France Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 36. Italy Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 37. Russia Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 39. China Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 40. China Glycopeptide Antibiotics Market Share by Type (2021-2032) Figure 41. China Glycopeptide Antibiotics Market Share by Application (2021-2032) Figure 42. Asia Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 43. Asia Glycopeptide Antibiotics Market Share by Type (2021-2032) Figure 44. Asia Glycopeptide Antibiotics Market Share by Application (2021-2032) Figure 45. Asia Glycopeptide Antibiotics Market Share by Country (2021-2032) Figure 46. Japan Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 50. India Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 51. Australia Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Glycopeptide Antibiotics Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Glycopeptide Antibiotics Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Glycopeptide Antibiotics Market Share by Country (2021-2032) Figure 56. Brazil Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 61. UAE Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 63. Chile Glycopeptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Vancomycin
  • Teicoplanin
  • Bleomycin
Applications
  • Enterococcus Treatment
  • Staphylococcus Aureus Treatment
Companies covered
  • Allergan
  • Alvogen
  • ANI Pharmaceuticals
  • Aurobindo Pharma
  • Hikma Pharmaceuticals plc
  • Lytix Biopharma
  • Theravance Biopharma
  • Eli Lilly and Company
  • Shenwei Pharmaceutical
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Glycopeptide Antibiotics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Vancomycin
  5. 1.2.3 Teicoplanin
  6. 1.2.4 Bleomycin
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Glycopeptide Antibiotics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Enterococcus Treatment
  10. 1.3.3 Staphylococcus Aureus Treatment
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Glycopeptide Antibiotics Growth Trends by Region
  13. 1.5.1 Global Glycopeptide Antibiotics Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Glycopeptide Antibiotics Market Size by Region (2021-2026)
  15. 1.5.3 Glycopeptide Antibiotics Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Glycopeptide Antibiotics Market Dynamics
  1. 2.1 Glycopeptide Antibiotics Industry Trends
  2. 2.2 Glycopeptide Antibiotics Industry Drivers
  3. 2.3 Glycopeptide Antibiotics Industry Opportunities and Challenges
  4. 2.4 Glycopeptide Antibiotics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Glycopeptide Antibiotics Revenue by Company (2021-2026)
  2. 3.2 Global Glycopeptide Antibiotics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Glycopeptide Antibiotics Key Company Head office and Area Served
  4. 3.4 Global Glycopeptide Antibiotics Company, Product Type & Application
  5. 3.5 Global Glycopeptide Antibiotics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Glycopeptide Antibiotics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Glycopeptide Antibiotics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Glycopeptide Antibiotics Tier 1, Tier 2, and Tier 3
4 Glycopeptide Antibiotics Market by Type
  1. 4.1 Global Glycopeptide Antibiotics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Glycopeptide Antibiotics Market Size by Type (2021-2032)
  3. 4.3 Global Glycopeptide Antibiotics Market Size Share by Type (2021-2032)
5 Glycopeptide Antibiotics Market by Application
  1. 5.1 Global Glycopeptide Antibiotics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Glycopeptide Antibiotics Market Size by Application (2021-2032)
  3. 5.3 Global Glycopeptide Antibiotics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Allergan
  2. 6.1.1 Allergan Company Information
  3. 6.1.2 Allergan Business Overview
  4. 6.1.3 Allergan Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Allergan Glycopeptide Antibiotics Product Portfolio
  6. 6.1.5 Allergan Recent Developments
  7. 6.2 Alvogen
  8. 6.2.1 Alvogen Company Information
  9. 6.2.2 Alvogen Business Overview
  10. 6.2.3 Alvogen Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Alvogen Glycopeptide Antibiotics Product Portfolio
  12. 6.2.5 Alvogen Recent Developments
  13. 6.3 ANI Pharmaceuticals
  14. 6.3.1 ANI Pharmaceuticals Company Information
  15. 6.3.2 ANI Pharmaceuticals Business Overview
  16. 6.3.3 ANI Pharmaceuticals Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 ANI Pharmaceuticals Glycopeptide Antibiotics Product Portfolio
  18. 6.3.5 ANI Pharmaceuticals Recent Developments
  19. 6.4 Aurobindo Pharma
  20. 6.4.1 Aurobindo Pharma Company Information
  21. 6.4.2 Aurobindo Pharma Business Overview
  22. 6.4.3 Aurobindo Pharma Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Aurobindo Pharma Glycopeptide Antibiotics Product Portfolio
  24. 6.4.5 Aurobindo Pharma Recent Developments
  25. 6.5 Hikma Pharmaceuticals plc
  26. 6.5.1 Hikma Pharmaceuticals plc Company Information
  27. 6.5.2 Hikma Pharmaceuticals plc Business Overview
  28. 6.5.3 Hikma Pharmaceuticals plc Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Hikma Pharmaceuticals plc Glycopeptide Antibiotics Product Portfolio
  30. 6.5.5 Hikma Pharmaceuticals plc Recent Developments
  31. 6.6 Lytix Biopharma
  32. 6.6.1 Lytix Biopharma Company Information
  33. 6.6.2 Lytix Biopharma Business Overview
  34. 6.6.3 Lytix Biopharma Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Lytix Biopharma Glycopeptide Antibiotics Product Portfolio
  36. 6.6.5 Lytix Biopharma Recent Developments
  37. 6.7 Theravance Biopharma
  38. 6.7.1 Theravance Biopharma Company Information
  39. 6.7.2 Theravance Biopharma Business Overview
  40. 6.7.3 Theravance Biopharma Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Theravance Biopharma Glycopeptide Antibiotics Product Portfolio
  42. 6.7.5 Theravance Biopharma Recent Developments
  43. 6.8 Eli Lilly and Company
  44. 6.8.1 Eli Lilly and Company Company Information
  45. 6.8.2 Eli Lilly and Company Business Overview
  46. 6.8.3 Eli Lilly and Company Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Eli Lilly and Company Glycopeptide Antibiotics Product Portfolio
  48. 6.8.5 Eli Lilly and Company Recent Developments
  49. 6.9 Shenwei Pharmaceutical
  50. 6.9.1 Shenwei Pharmaceutical Company Information
  51. 6.9.2 Shenwei Pharmaceutical Business Overview
  52. 6.9.3 Shenwei Pharmaceutical Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Shenwei Pharmaceutical Glycopeptide Antibiotics Product Portfolio
  54. 6.9.5 Shenwei Pharmaceutical Recent Developments
  55. 6.10 Zhejiang Hisun Pharmaceutical Co., Ltd.
  56. 6.10.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Product Portfolio
  60. 6.10.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
7 North America
  1. 7.1 North America Glycopeptide Antibiotics Market Size (2021-2032)
  2. 7.2 North America Glycopeptide Antibiotics Market Size by Type
  3. 7.2.1 North America Glycopeptide Antibiotics Market Size by Type (2021-2026)
  4. 7.2.2 North America Glycopeptide Antibiotics Market Size by Type (2027-2032)
  5. 7.2.3 North America Glycopeptide Antibiotics Market Share by Type (2021-2032)
  6. 7.3 North America Glycopeptide Antibiotics Market Size by Application
  7. 7.3.1 North America Glycopeptide Antibiotics Market Size by Application (2021-2026)
  8. 7.3.2 North America Glycopeptide Antibiotics Market Size by Application (2027-2032)
  9. 7.3.3 North America Glycopeptide Antibiotics Market Share by Application (2021-2032)
  10. 7.4 North America Glycopeptide Antibiotics Market Size by Country
  11. 7.4.1 North America Glycopeptide Antibiotics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Glycopeptide Antibiotics Market Size by Country (2021-2026)
  13. 7.4.3 North America Glycopeptide Antibiotics Market Size by Country (2027-2032)
  14. 7.4.4 North America Glycopeptide Antibiotics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Glycopeptide Antibiotics Market Size (2021-2032)
  2. 8.2 Europe Glycopeptide Antibiotics Market Size by Type
  3. 8.2.1 Europe Glycopeptide Antibiotics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Glycopeptide Antibiotics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Glycopeptide Antibiotics Market Share by Type (2021-2032)
  6. 8.3 Europe Glycopeptide Antibiotics Market Size by Application
  7. 8.3.1 Europe Glycopeptide Antibiotics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Glycopeptide Antibiotics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Glycopeptide Antibiotics Market Share by Application (2021-2032)
  10. 8.4 Europe Glycopeptide Antibiotics Market Size by Country
  11. 8.4.1 Europe Glycopeptide Antibiotics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Glycopeptide Antibiotics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Glycopeptide Antibiotics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Glycopeptide Antibiotics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Glycopeptide Antibiotics Market Size (2021-2032)
  2. 9.2 China Glycopeptide Antibiotics Market Size by Type
  3. 9.2.1 China Glycopeptide Antibiotics Market Size by Type (2021-2026)
  4. 9.2.2 China Glycopeptide Antibiotics Market Size by Type (2027-2032)
  5. 9.2.3 China Glycopeptide Antibiotics Market Share by Type (2021-2032)
  6. 9.3 China Glycopeptide Antibiotics Market Size by Application
  7. 9.3.1 China Glycopeptide Antibiotics Market Size by Application (2021-2026)
  8. 9.3.2 China Glycopeptide Antibiotics Market Size by Application (2027-2032)
  9. 9.3.3 China Glycopeptide Antibiotics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Glycopeptide Antibiotics Market Size (2021-2032)
  2. 10.2 Asia Glycopeptide Antibiotics Market Size by Type
  3. 10.2.1 Asia Glycopeptide Antibiotics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Glycopeptide Antibiotics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Glycopeptide Antibiotics Market Share by Type (2021-2032)
  6. 10.3 Asia Glycopeptide Antibiotics Market Size by Application
  7. 10.3.1 Asia Glycopeptide Antibiotics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Glycopeptide Antibiotics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Glycopeptide Antibiotics Market Share by Application (2021-2032)
  10. 10.4 Asia Glycopeptide Antibiotics Market Size by Country
  11. 10.4.1 Asia Glycopeptide Antibiotics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Glycopeptide Antibiotics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Glycopeptide Antibiotics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Glycopeptide Antibiotics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Glycopeptide Antibiotics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Glycopeptide Antibiotics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Glycopeptide Antibiotics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Glycopeptide Antibiotics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Glycopeptide Antibiotics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst